Kymera Therapeutics KYMR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.23M-5.6% | -$86.98M-22.9% | -$82.18M-31.5% | -$76.61M-82.1% | -$65.58M-35.1% | ||
| $2.02M-1.3% | $2.03M+2.3% | $2.15M+8.2% | $2.08M+7.5% | $2.05M+40.2% | ||
| $16.01M+12.5% | $14.45M+4.7% | $15.8M+6.0% | $15.42M+7.5% | $14.23M+18.9% | ||
| -$88.84M-12.2% | -$66.75M-8.0% | -$27.11M+46.0% | -$59.88M-39.5% | -$79.15M-99.9% | ||
| $434K-7.1% | $106K-88.7% | $181K— | $695K-85.2% | $467K-93.7% | ||
| -$142.84M-394% | -$394.4M— | -$235.3M-49.2% | $60.02M— | $48.62M+115% | ||
| $18.77M+7,175% | $705.22M+25,405% | $39.51M-84.3% | $245.73M+17,303% | $258K-99.9% | ||
| -$212.91M-603% | $244.07M+2,456% | -$222.9M-618% | $245.86M+1,050% | -$30.28M-84.1% | ||
| -$89.27M-12.1% | -$66.85M-6.6% | -$27.29M+45.4% | -$60.58M-27.2% | -$79.62M-69.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kymera Therapeutics generate?
- Kymera Therapeutics (KYMR) generated -$242.6M in operating cash flow over the trailing twelve months.
- What is Kymera Therapeutics's free cash flow?
- After $1.4M of capital expenditures, Kymera Therapeutics's free cash flow was -$244.0M over the trailing twelve months, down 1.7% year over year.
- Where does Kymera Therapeutics's cash flow data come from?
- Every line is extracted from Kymera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
